Dicloxacillin Sodium
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Dicloxacillin Sodium contains the equivalent of NLT 850 µg/mg of dicloxacillin (C19H17Cl2N3O5S).
2 IDENTIFICATION
Change to read:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K (CN 1-May-2020)
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
C. Identification Tests—General 〈191〉, Sodium
Analysis: Ignite about 100 mg. Proceed as directed in the chapter using a solution (1 in 20) of the residue in acetic acid. Acceptance criteria: Meets the requirements
3 ASSAY
3.1 Procedure
Protect solutions containing dicloxacillin from light.
Solution A: 1.18 g/L of sodium 1-hexanesulfonate monohydrate and 0.8 mL/L of ammonium hydroxide in water; adjusted with phosphoric acid to a pH of 2.9–3.1
Solution B: Acetonitrile
Mobile phase: See Table 1.
Table 1
Time (min) | Solution A (%) | Solution B (%) |
| 0 | 45 | 55 |
| 2 | 45 | 55 |
| 2.5 | 35 | 65 |
| 5 | 35 | 65 |
Return to the original conditions and re-equilibrate the system.
Diluent: Acetonitrile and water (50:50)
System suitability stock solution: 0.1 mg/mL of USP Dicloxacillin Related Compound D RS in Diluent. Sonicate as needed to dissolve. System suitability solution: 0.001 mg/mL of USP Dicloxacillin Related Compound D RS from the System suitability stock solution and 0.1 mg/mL of USP Dicloxacillin Sodium RS in Diluent. Store this solution at 4°.
Standard solution: 0.1 mg/mL of USP Dicloxacillin Sodium RS in Diluent. Sonicate as needed to dissolve. Store this solution at 4°. Sample solution: 0.1 mg/mL of Dicloxacillin Sodium in Diluent. Sonicate as needed to dissolve. Store this solution at 4°.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 225 nm
Column: 4.6-mm × 25-cm; 5-µm packing L1
Temperatures
Autosampler: 4°
Column: 40°
Flow rate: 1.5 mL/min
Injection volume: 10 µL
System suitability
Samples: System suitability solution and Standard solution
[Note—The relative retention times for dicloxacillin and dicloxacillin related compound D are about 1.0 and 1.1, respectively.] Suitability requirements
Resolution: NLT 1.5 between dicloxacillin and dicloxacillin related compound D, System suitability solution
Tailing factor: 0.8–1.5, Standard solution
Relative standard deviation: NMT 0.73%, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the quantity, in µg/mg, of dicloxacillin (C19H17Cl2N3O5S) in the portion of Dicloxacillin Sodium taken:
Result = (ru/rs) × (Cs/Cu) × P
ru = peak response from the Sample solution
rs = peak response from the Standard solution
Cs = concentration of USP Dicloxacillin Sodium RS in the Standard solution (mg/mL)
Cu = concentration of Dicloxacillin Sodium in the Sample solution (mg/mL)
P = potency of dicloxacillin in USP Dicloxacillin Sodium RS (µg/mg)
Acceptance criteria: NLT 850 µg/mg
4 IMPURITIES
4.1 Organic Impurities
Protect solutions containing dicloxacillin from light.
Solution A, Solution B, Diluent, and Chromatographic system: Proceed as directed in the Assay.
Mobile phase: See Table 2.
Table 2
Time (min) | Solution A (%) | Solution B (%) |
| 0 | 70 | 30 |
| 10 | 70 | 30 |
| 30 | 50 | 50 |
| 35 | 35 | 65 |
| 45 | 25 | 75 |
Return to the original conditions and re-equilibrate the system.
System suitability stock solution: 0.1 mg/mL of USP Dicloxacillin Related Compound D RS in Diluent
System suitability solution: 0.01 mg/mL of USP Dicloxacillin Related Compound D RS from the System suitability stock solution and 1 mg/mL of USP Dicloxacillin Sodium RS in Diluent. Store this solution at 4°.
Standard solution: 0.01 mg/mL of USP Dicloxacillin Sodium RS in Diluent. Sonicate as needed to dissolve. Store this solution at 4°. Sample solution: 1 mg/mL of Dicloxacillin Sodium in Diluent. Sonicate as needed to dissolve. Store this solution at 4°.
System suitability
Samples: System suitability solution and Standard solution
Suitability requirements
Resolution: NLT 1.5 between dicloxacillin related compound D and dicloxacillin, System suitability solution Tailing factor: 0.8–1.5, Standard solution
Relative standard deviation: NMT 2.5%, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each impurity in the portion of Dicloxacillin Sodium taken:
Result = (ru/rs) × (Cs/Cu) × P × (F1/F2) × 100
ru = peak response of each impurity from the Sample solution
rs = peak response from the Standard solution
Cs = concentration of USP Dicloxacillin Sodium RS in the Standard solution (mg/mL)
Cu = concentration of Dicloxacillin Sodium in the Sample solution (mg/mL)
P = potency of dicloxacillin in USP Dicloxacillin Sodium RS (µg/mg)
F1 = conversion factor, 0.001 mg/µg
F2 = relative response factor (see Table 3)
Acceptance criteria
Individual impurities: NMT 1.0%
Total impurities: NMT 5.0%
See Table 3 for relative retention times and relative response factors. The reporting threshold is 0.05%.
Table 3
| Name | Relative Retention Time | Relative Response Factor |
| Amoxicillin related compound A | 0.07 | 0.20 |
| Dicloxacillin penicilloic acid | 0.23 | 1.0 |
| 0.25 | ||
| Dicloxacillin glycine analog | 0.38 | 1.0 |
| Dicloxacillin N-acetyl penicilloic acid | 0.43 | 1.0 |
| Dicloxacillin penilloic acid | 0.61 | 0.75 |
| 0.69 | ||
| Dicloxacillin related compound D | 0.90 | 1.4 |
| Dicloxacillin | 1.0 | _ |
| Dicloxacillin penicillamide | 1.3 | 1.0 |
a 6-Aminopenicillanic acid; (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid.
b The system resolves two isomers.
c (4S)-2-{Carboxy[3-(2,6-dichlorophenyl)-5-methylisoxazole-4-carboxamido]methyl}-5,5-dimethylthiazolidine-4-carboxylic acid.
d [3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carbonyl]glycine.
e (2R,4S)-3-Acetyl-2-{(R)-carboxy[3-(2,6-dichlorophenyl)-5-methylisoxazole-4-carboxamido]methyl}-5,5-dimethylthiazolidine-4-carboxylic acid.
f (4S)-2-{[3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carboxamido]methyl}-5,5-dimethylthiazolidine-4-carboxylic acid.
g 3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carboxylic acid.
h (2S,5R,6R)-6-{(2S,5R,6R)-6-[3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carboxamido]-3,3-dimethyl-7-oxo-4-thia-1- azabicyclo[3.2.0]heptane-2-carboxamido}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid.
4.2 Dimethylaniline 〈223〉: Meets the requirements
5 SPECIFIC TESTS
5.1 Crystallinity 〈695〉: Meets the requirements
5.2 pH 〈791〉
Sample solution: 10 mg/mL in water
Acceptance criteria: 4.5–7.5
5.3 Water Determination 〈921〉, Method I: 3.0%–5.0%
6 ADDITIONAL REQUIREMENTS
6.1 Packaging and Storage: Preserve in tight containers.
6.2 USP Reference Standards 〈11〉
USP Dicloxacillin Sodium RS
USP Dicloxacillin Related Compound D RS
3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carboxylic acid.
C11H7Cl2NO3 272.08

